Nontuberculous Mycobacteria.

Area of Science:

• Pulmonary Medicine
• Infectious Diseases
• Microbiology

Background:

• Nontuberculous mycobacteria (NTM) are widespread environmental bacteria with diverse virulence.
• Pulmonary NTM disease (NTM PD) is the most common manifestation, with bronchiectasis as a key risk factor.
• Accurate diagnosis and targeted treatment are crucial for managing NTM infections.

Purpose of the Study:

• To provide clinicians with a framework for managing bronchiectasis and NTM PD.
• To review the epidemiology, pathogenesis, diagnosis, and management of NTM PD.
• To highlight diagnostic challenges and the importance of species identification for guiding treatment.

Main Methods:

• Literature review of NTM epidemiology, pathogenesis, and clinical management.
• Discussion of diagnostic approaches, including challenges in NTM PD detection.
• Detailed review of treatment strategies for Mycobacterium avium complex and Mycobacterium abscessus infections.

Main Results:

• NTM PD is a significant clinical concern, especially in patients with bronchiectasis.
• Subspeciation of NTM is critical for effective treatment and patient follow-up.
• The 2020 ATS/ERS/ESCMID/IDSA NTM guidelines offer updated management recommendations.

Conclusions:

• Effective management of NTM PD requires a thorough understanding of NTM biology and clinical presentation.
• Early and accurate diagnosis, coupled with appropriate antimicrobial therapy, improves patient outcomes.
• Adherence to current guidelines is essential for optimizing the care of patients with NTM lung disease.